Pfizer has made a new and improved bid to acquire AstraZeneca with an offer worth £69.3 billion pounds ($116.6 billion) or £55 a share – and says this is its best and final offer for the firm.

Leading vaccine makers like Eli Lilly and Co. (NYSE: LLY), Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic ...

Pfizer: It is one of the largest and most successful ... Lilly’s stock has risen 25% in the past year. AstraZeneca: It boasts a diversified geographical footprint as well as a product portfolio ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

The latest health news highlights Trump considering an executive order to protect gas stoves, warnings for GSK's and Pfizer's ...

The Digital Marketing Competency Report ranks each individual brand on a scale ranging from Transformational to Novice. It examines time in market, therapeutic areas and impact on individual ...

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, released its fourth annual TGaS Digital Marketing Competency ...